Ginkgo biloba

DB01381ApprovedInvestigationalNutraceuticalOrganism Based Therapies

Ginkgo biloba is a herbal supplement found in over-the-counter or unapproved homeopathic products for various health conditions, such as cognitive, neurodegenerative, cardiovascular, and reproductive health disorders. Ginkgo biloba extract contains a group of terpene lactones (notably, ginkgolides and diterpenes) and ginkgo flavone glycosides (notably, ginkgetin, bilobetin, and sciadopitysin) that have antioxidant and vasoactive properties.

Mechanism
Curator reviewed · 10 references
Primary indication
Ginkgo biloba does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use.Curator reviewed · 3 structured indications
Also known as
Common ginkgo leaf · Ginkgo · Ginkgo biloba extract · Ginkgo biloba leaf · Ginkgo biloba leaf dry extract
Code names
B1260 · EGB-761

Resolves to

What you can answer from here — as of July 17, 2026

8Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
735Drug interactionsStructured to mechanism, not free text
Sign in
85Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
269Marketed productsAcross 6 countries and 26 labellers
Sign in
2ATC codesIncluding every combination product, plus 30 drug categories
Sign in
31+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ginkgo biloba, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account